Skip to main content
Erschienen in: Clinical Journal of Gastroenterology 1/2018

01.11.2017 | Case Report

A Caucasian American patient with celiac disease diagnosed in Japan and successfully treated with a gluten-free diet

verfasst von: Haruka Wada, Mari Hayashida, Taro Sato, Shintaro Minowa, Osamu Ikezaki, Tatsuya Mitsui, Miki Miura, Yoshihiko Ohmori, Daisuke Saito, Akihito Sakuraba, Hideo Kamiichi, Kengo Tokunaga, Makoto Mochizuki, Junji Shibahara, Hideaki Mori, Tadakazu Hisamatsu

Erschienen in: Clinical Journal of Gastroenterology | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

We report the case of a 33-year-old Caucasian American man diagnosed with celiac disease in Japan. He presented to a community hospital because of chronic watery diarrhea and weight loss for 6 months. The laboratory data showed low serum albumin and serum cholesterol. A colonoscopy was normal. He was referred to our hospital for further work-up. Serum tissue transglutaminase immunoglobulin A (IgA) and endomysial antibody were positive. The HLA type was DQ2. Esophagogastroduodenoscopy (EGD) revealed nodular and mosaic-patterned mucosa from the bulb to the second part of the duodenum. The histopathological findings were consistent with Marsh type 3c of the modified Marsh classification for celiac disease. The patient was instructed to follow a gluten-free diet (GFD). Six months after the initiation of the GFD, his symptom and the levels of serum albumin and cholesterol were improved, and the serum tissue transglutaminase IgA and endomysial antibody became negative. However, EGD showed little improvement. Capsule endoscopy also revealed mosaic-patterned mucosa, nodular mucosa, and scalloping of the folds of the duodenum and proximal small intestine. There was no definite improvement in histopathological findings. Collectively, the GFD was effective in this patient with celiac disease, but it should be maintained to achieve endoscopic and histopathologic healing.
Literatur
2.
Zurück zum Zitat Rubio-Tapia A, Hill ID, Kelly CP, et al. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol. 2013;108:656–76.CrossRefPubMedPubMedCentral Rubio-Tapia A, Hill ID, Kelly CP, et al. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol. 2013;108:656–76.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Dickey W. Endoscopic markers for celiac disease. Nat Clin Pract Gastroenterol Hepatol. 2006;3:546–51.CrossRefPubMed Dickey W. Endoscopic markers for celiac disease. Nat Clin Pract Gastroenterol Hepatol. 2006;3:546–51.CrossRefPubMed
5.
Zurück zum Zitat Cummins AG, Roberts-Thomson IC. Prevalence of celiac disease in the Asia-Pacific region. J Gastroenterol Hepatol. 2009;24:1347–51.CrossRefPubMed Cummins AG, Roberts-Thomson IC. Prevalence of celiac disease in the Asia-Pacific region. J Gastroenterol Hepatol. 2009;24:1347–51.CrossRefPubMed
6.
Zurück zum Zitat Rubio-Tapia A, Rahim MW, See JA, et al. Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet. Am J Gastroenterol. 2010;105:1412–20.CrossRefPubMedPubMedCentral Rubio-Tapia A, Rahim MW, See JA, et al. Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet. Am J Gastroenterol. 2010;105:1412–20.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Hære P, Høie O, Schulz T, et al. Long-term mucosal recovery and healing in celiac disease is the rule − not the exception. Scand J Gastroenterol. 2016;51:1439–46.CrossRefPubMed Hære P, Høie O, Schulz T, et al. Long-term mucosal recovery and healing in celiac disease is the rule − not the exception. Scand J Gastroenterol. 2016;51:1439–46.CrossRefPubMed
8.
Zurück zum Zitat Ertekin V, Selimoğlu MA, Turgut A, et al. Fecal calprotectin concentration in celiac disease. J Clin Gastroenterol. 2010;44:544–6.PubMed Ertekin V, Selimoğlu MA, Turgut A, et al. Fecal calprotectin concentration in celiac disease. J Clin Gastroenterol. 2010;44:544–6.PubMed
9.
Zurück zum Zitat Nakazawa H, Makishima H, Ito T, et al. Screening tests using serum tissue transglutaminase IgA may facilitate the identification of undiagnosed celiac disease among Japanese population. Int J Med Sci. 2014;11:819–23.CrossRefPubMedPubMedCentral Nakazawa H, Makishima H, Ito T, et al. Screening tests using serum tissue transglutaminase IgA may facilitate the identification of undiagnosed celiac disease among Japanese population. Int J Med Sci. 2014;11:819–23.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Elfström P, Granath F, Ekström Smedby K, et al. Risk of lymphoproliferative malignancy in relation to small intestinal histopathology among patients with celiac disease. J Natl Cancer Inst. 2011;103:436–44.CrossRefPubMed Elfström P, Granath F, Ekström Smedby K, et al. Risk of lymphoproliferative malignancy in relation to small intestinal histopathology among patients with celiac disease. J Natl Cancer Inst. 2011;103:436–44.CrossRefPubMed
Metadaten
Titel
A Caucasian American patient with celiac disease diagnosed in Japan and successfully treated with a gluten-free diet
verfasst von
Haruka Wada
Mari Hayashida
Taro Sato
Shintaro Minowa
Osamu Ikezaki
Tatsuya Mitsui
Miki Miura
Yoshihiko Ohmori
Daisuke Saito
Akihito Sakuraba
Hideo Kamiichi
Kengo Tokunaga
Makoto Mochizuki
Junji Shibahara
Hideaki Mori
Tadakazu Hisamatsu
Publikationsdatum
01.11.2017
Verlag
Springer Japan
Erschienen in
Clinical Journal of Gastroenterology / Ausgabe 1/2018
Print ISSN: 1865-7257
Elektronische ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-017-0794-4

Weitere Artikel der Ausgabe 1/2018

Clinical Journal of Gastroenterology 1/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.